Anthony Bergmann

CIK: 0001593087

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (31.3%)

Position reduction

Option Exercises (M)7 (43.8%)

Derivative conversions

Awards (A)4 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAPR

CAPRICOR THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 25, 2026
Sale(S)
Direct
24.1K shares at avg. $30.38$732K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 25, 2026
Exercise(M)
Direct
24.1K shares at avg. $3.18$77K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 24, 2026
Sale(S)
Direct
400 shares at avg. $30.00$12K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 24, 2026
Exercise(M)
Direct
400 shares at avg. $3.18$1K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 22, 2026
Exercise(M)
Direct
500 shares at avg. $3.18$2K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jun 22, 2026
Sale(S)
Direct
500 shares at avg. $30.00$15K
CAPR
CAPRICOR THERAPEUTICS, INC.
May 18, 2026
Exercise(M)
Direct
3K shares at avg. $1.39$4K
CAPR
CAPRICOR THERAPEUTICS, INC.
May 1, 2026
Exercise(M)
Direct
25K shares at avg. $3.18$80K
CAPR
CAPRICOR THERAPEUTICS, INC.
May 1, 2026
Sale(S)
Direct
25K shares at avg. $31.70$793K
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 31, 2026
Exercise(M)
Direct
25K shares at avg. $3.18$80K
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 31, 2026
Sale(S)
Direct
25K shares at avg. $30.13$753K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Restricted Stock Units
Direct
2.5K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 3, 2025
Exercise(M)
Direct
2.5K shares at avg. $1.39$3K
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Direct
3.3K shares-

		Type	Shares	Price		Ownership
Jun 25, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	24,100	$30.38	$732,158	Direct
Jun 25, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	24,100	$3.18	$76,638	Direct
Jun 24, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	400	$30.00	$12,000	Direct
Jun 24, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	400	$3.18	$1,272	Direct
Jun 22, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	500	$3.18	$1,590	Direct
Jun 22, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	500	$30.00	$15,000	Direct
May 18, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	3,000	$1.39	$4,170	Direct
May 1, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	25,000	$3.18	$79,500	Direct
May 1, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	25,000	$31.70	$792,540	Direct
Mar 31, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	25,000	$3.18	$79,500	Direct
Mar 31, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	25,000	$30.13	$753,153	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Restricted Stock Units	2,500	-	-	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Direct
Mar 3, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	2,500	$1.39	$3,475	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A)	3,342	-	$0	Direct

1-16 of 16 transactions

About Bergmann Anthony

Bergmann Anthony (SEC CIK 0001593087) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of CAPRICOR THERAPEUTICS, INC. (CAPR).

Signal8 holds 8 ownership filings by Bergmann Anthony, all Form 4s, filed between Jan 6, 2025 and Jun 29, 2026. Those filings report 16 transactions, from Jan 2, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bergmann Anthony's filings is in SAN DIEGO, CA.

Recent filings by Bergmann Anthony

Jun 25, 2026: Open-market sale of CAPR shares (Form 4, code S).
Jun 25, 2026: Option exercise of CAPR shares (Form 4, code M).
Jun 24, 2026: Open-market sale of CAPR shares (Form 4, code S).
Jun 24, 2026: Option exercise of CAPR shares (Form 4, code M).
Jun 22, 2026: Option exercise of CAPR shares (Form 4, code M).

Other insiders filing for CAPRICOR THERAPEUTICS, INC. (CAPR)

Krasney Karen, EVP, GENERAL COUNSEL
Maurer Michael T, CHIEF COMMERCIAL OFFICER
Litvack Frank, Director
Sabar Karimah Es, Director
Marban Linda, CHIEF EXECUTIVE OFFICER
Auwaerter Paul Gisbert, Director

How to read Form 4 transaction codes